| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $75.0M | +23.1% |
| SG&A Expense | $28.3M | +25.2% |
| Operating Income | -$103.3M | -25.1% |
| Pre-tax Income | -$90.4M | -20.2% |
| Income Tax | $0 | — |
| Net Income | -$90.4M | -20.2% |
| EPS (Basic) | -$4.24 | +0.9% |
| EPS (Diluted) | -$4.24 | +0.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.8M | -24.0% |
| Short-term Investments | $165.2M | -6.1% |
| Current Assets | $271.8M | -14.0% |
| Total Assets | $288.6M | -14.0% |
| Current Liabilities | $16.4M | +8.3% |
| Total Liabilities | $23.7M | -6.5% |
| Stockholders' Equity | $264.9M | -14.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$77.2M | -9.3% |
| Capital Expenditures | $1.2M | +46.4% |
| Investing Cash Flow | $14.0M | +111.2% |
| Financing Cash Flow | $30.4M | -83.5% |
| Free Cash Flow | -$78.4M | -9.7% |